Sorafenibe pelo plano de saúde: advogado explica regra da ANS para cobertura do medicamento

(10:46)

Tislelizumab OS benefit vs sorafenib as first line treatment for unresectable hepatocellular car...

(3:12)

Dr. Pinato on Study of Sorafenib in Pretreated Patients With HCC

(1:27)

Sorafenib Fails in Metastatic Breast Cancer

(2:50)

HCC: Use of Lenvatinib and Sorafenib

(6:51)

Sorafenib: The Current Standard of Care

(6:50)

DESENVOLVIMENTO DE INIBIDORES DE CÉLULAS TUMORAIS DERIVADOS DO SORAFENIBE

(5:1econd)

Regorafenibe pelo plano de saúde: advogado explica regra da ANS para cobertura do medicamento

(10:48)

05 - Sorafenib maintenance after Allo HSCT in patients with FLT3-ITD AML: long-term follow-up

(31:12)

2019 Pelotonia Idea Grants: Christin E. Burd, PhD

(1:40)

How to support cancer research through Pelotonia 2022 | OSUCCC – James

(1:1econd)

Nexavar Industrial

(1:44)

My Pelotonia: Sara's story

(4:52)

2020 Pelotonia Fellows: Ben Stromberg

(2:22)

2018 Pelotonia Fellowship: Kirti Kaul

(2:9)

Quais são os novos tratamentos para o câncer de fígado?

(2:32)

\

(4:56)

2019 Pelotonia Fellowships at The James

(1:40)

Perioperative Complications and Oncologic Outcomes of Nephrectomy Fwing IO Therapy- Kaique da Rosa

(56:35)